Archives

by in
Entry Author Date Location
East Coast Biotech Roundup: Enanta, NY Disruptors, Repligen, & More 01/24/14 Boston
Social Media & Cancer Drugs: Conversation, not Promotion 01/23/14 Wisconsin
Promentis’s $2.9M Series B Round to Fund Human Trials 01/16/14 Wisconsin
San Diego Life Sciences Roundup: Receptos, Auspex, Avelas, and More 01/10/14 San Diego
Ariad’s Cancer Drug to Return to U.S. in January, Shares Soar 12/20/13 Boston
How WARF Plans to Stay Relevant in Lean Times for Tech Transfer 12/20/13 Wisconsin
Houston’s Decisio Crunches Patient Data for Better Care 12/18/13 Texas
Exact Sciences, Once Near Death, Bounces Back With Colon Cancer Test 12/18/13 Wisconsin
What Was Hyped, and What Fell Out of Favor, This Year in Biotech 12/16/13 National
San Diego Life Sciences Roundup: Orexigen, Accelrys, Otonomy, & More 12/13/13 San Diego
There May Be More to the FDA/23andMe Story Than Meets the Eye 12/12/13 Boston
Savient Pharma Sells to GTCR-Backed Crealta For $120M 12/11/13 New York
12 Things the Pharma Industry Can Do to Rebuild Real Public Trust 12/09/13 National
San Diego Life Sciences Roundup: Ignyta, Conatus, Liver Prize & More 12/06/13 San Diego
FDA’s Culture Is Genetically Dominant Over 23andMe’s Business Model 12/05/13 National
San Diego Life Sciences Roundup: Orexigen, Avalon, GSK, and More 11/27/13 San Diego
23andMe: Victim of an Overboard FDA Crackdown, or Provocateur? 11/26/13 Seattle
East Coast Biotech Roundup: Sarepta, Zalicus, Alkermes, & More 11/15/13 Boston
Sarepta Shares Crumble As FDA Calls New Drug Application “Premature” 11/12/13 Boston
Axe Falls on Ariad’s Workforce After Cancer Drug Blowup 11/07/13 Boston
Curis Shares Tumble As Cancer Drug Slapped With FDA Clinical Hold 11/06/13 Boston
Genentech Does it Again, Wins FDA Approval for ‘Son of Rituxan’ 11/01/13 San Francisco
San Diego Life Sciences Roundup: Zogenix, Illumina, Sophiris, & More 11/01/13 San Diego
Immune Design Grabs $32.5M, Cashing in on Cancer Immunotherapy Rush 10/30/13 Seattle
An Insider’s Antidote for Dangerous Stem Cell Hype 10/22/13 San Francisco
PSivida, Alimera Shares Fall as FDA Rejects Eye Drug for Third Time 10/18/13 Boston
Ariad Halts Leukemia Drug Trials Due to Safety Concerns, Shares Plummet 10/09/13 Boston
San Diego Life Sciences Roundup: Fate, Ligand, BioNano, and More 10/04/13 San Diego
San Diego Life Sciences Roundup: Isis, Neurocrine, MEI, and More 09/12/13 San Diego
FDA Concerns Cause OvaScience To Halt U.S. Trial Of Souped-Up IVF Procedure 09/11/13 Boston
Page 2 of 38 « previous page · next page »